Tutorials › Adaptive Clinical Trial Design › Participant and Site Transitions When Arms Change

Adaptive Platform Governance · Tutorial 720 of 799

Participant and Site Transitions When Arms Change

Build a clear, accountable transition process that protects participant follow-up and prevents sites from acting on conflicting arm instructions.

Intermediate 10 min read

What You'll Learn

  • Distinguish an arm’s operational status from each participant’s follow-up status.
  • Set effective dates and times that sites can apply consistently.
  • Assign responsibility for recruitment pauses, participant care, and transition communications.
  • Plan follow-up when an arm closes without treating closure as automatic discontinuation.
  • Identify transition failures using status records, reconciliations, and escalation routes.

Why Transitions Need Explicit Governance

An arm opening, closing, or changing is not a single event at every site. A decision may be made centrally, but sites still need to know when recruitment rules change, what to tell participants, which follow-up activities remain due, and whom to contact when the instruction does not fit a participant’s circumstances. If those details are left implicit, different sites can act on different versions of the decision.

This tutorial focuses on operational responsibility during those transitions. It does not replace the approved protocol or change-control process. Rather, it shows how to translate an authorized arm decision into coordinated actions for participants and sites. Earlier material on decision rights and delegation maps, arm closure, and change control provides the governance basis: the transition plan should identify who has authority to decide, who implements the decision, and which controlled instructions sites must follow.

Definition: An arm transition is the governed change from one operational status of a treatment arm to another, such as not yet open to open, open to recruitment paused, paused to open, or open to closed. A transition plan specifies the effective time, affected activities and people, responsible roles, site instructions, and the records that demonstrate completion. Arm status describes the arm; it does not by itself determine the care or follow-up status of any individual participant.

A useful plan separates three questions. First, what is the arm’s status, and from what time? Second, what happens to recruitment and screening activity at each site? Third, what does the approved protocol require for participants already assigned to the arm? These questions are connected, but the answers should not be collapsed into a single instruction such as “stop the arm.” Closing an arm to new recruitment does not, by itself, mean that participants stop treatment, visits, safety monitoring, or other protocol-required follow-up.

A Responsibility Structure for the Transition

Before communicating a transition, establish a common operational record. At minimum, it should identify the authorized decision and its scope; the arm and sites affected; the effective date, time, and time zone; whether screening, consent, randomization, or treatment allocation is permitted; the instructions for participants already in follow-up; the communication owner; and the route for questions or exceptions. These details should align with the current approved documents and applicable local requirements.

The effective time matters because a site may have candidates at different stages. A direction to “stop enrollment immediately” can be ambiguous if one person has consented but has not yet been randomized and another has already been assigned. The transition notice should state which operational event determines whether an action is allowed, using the protocol’s terms. It should not invite sites to infer a cutoff from when they happen to read an email.

Responsibility should be assigned by task, not just by committee or department. The authorized governance body may approve the transition; an operational lead may coordinate implementation; a designated site contact may confirm local receipt and reconcile records; and the investigator remains responsible for participant-level conduct at the site. The specific allocation depends on the platform’s approved governance and delegation arrangements. A communication should not transfer clinical responsibility merely because a central team sent it.

Transition taskWhat must be clearUseful evidence of completion
Authorize the changeDecision-maker, scope, rationale, and any conditionsApproved decision record
Set the effective boundaryDate, time, time zone, and operational event affectedControlled notice with effective time
Implement at sitesWhat staff must stop, continue, or begin doingSite acknowledgement and local action log
Protect follow-upApplicable participant instructions and escalation routeReconciled participant follow-up list
Close the communication loopWho answers questions and handles discrepanciesIssue log with owner and resolution

Deriving a Minimal Transition Check

A transition is safe to implement only if the operational instruction can be applied consistently to every affected site and participant without guessing. This gives a simple justification for a minimum check. For each affected unit, the team needs a status, a boundary for when that status applies, and an accountable owner. If any of these is missing, two staff members could reasonably take different actions.

1
Specify the status change.
Name the prior and new arm status, and define the exact operational activity affected. “Closed” is not sufficient if it is unclear whether screening, randomization, or treatment initiation is meant.
2
Define the boundary.
State when the new instruction begins and what event is used to classify activity on either side of that time. Apply the same defined event across sites.
3
Assign an owner and a record.
Identify who implements each action and what evidence will show that it was completed. The decision is not fully operational until sites know how to report completion or raise a discrepancy.

The logic is straightforward: a status without a boundary is not consistently actionable; a boundary without a defined activity leaves the scope uncertain; and both without an owner leave execution unaccountable. The check is therefore not an additional approval layer. It is a way to make an authorized decision implementable and auditable.

Worked Example: Closing Recruitment at a Defined Cutoff

Hypothetical scenario. A platform authorizes closure of Arm B to new randomization at 17:00 UTC on 14 October. The notice applies to six sites. At the cutoff, the central record shows 31 participants randomized to Arm B before 17:00 UTC, two consented candidates not yet randomized, and four people in screening who have not consented.

The notice defines randomization as the boundary event. Therefore, the 31 people randomized before the cutoff remain participants assigned to Arm B and continue according to the applicable approved follow-up plan. The two consented candidates have not crossed the stated randomization boundary; sites must not randomize them to Arm B after 17:00 UTC. Their next steps must follow the approved protocol and the specific transition instructions, rather than an improvised decision to assign them elsewhere. The four people still in screening must not be treated as already enrolled in the arm.

For a basic reconciliation, the expected pre-cutoff randomized count is 31, and the expected post-cutoff Arm B randomization count is 0. If one site reports a participant randomized at 17:12 UTC, the discrepancy is not resolved by assuming the site “probably meant” the earlier time. The operational lead checks the timestamp, time zone, and source record, then follows the predefined escalation route and documents the resolution.

The transition is complete only when all six sites have received the notice, acknowledged the cutoff, confirmed that Arm B randomization is disabled or otherwise controlled as required, and reconciled any candidates in process. The central team records the two consented candidates and four screening candidates as requiring disposition under the authorized instructions. This keeps closure of recruitment distinct from decisions about individual care.

Participant Follow-Up Does Not End With Arm Closure

A closed arm may still have participants receiving treatment or completing follow-up. The transition plan should state which protocol version and follow-up requirements apply to these participants, who remains responsible for visits and safety reporting, and how participants can obtain clinical help. If a change proposes to alter an individual’s treatment or follow-up, it must be handled under the approved protocol and applicable authorization; an operational closure notice alone is not a clinical instruction to discontinue treatment.

Planning should also account for foreseeable operational details: visits already scheduled, pending safety assessments, outstanding data queries that affect care or safety review, study drug or device accountability where relevant, and contact arrangements if a site team changes. The plan should make clear who maintains oversight if a participant transfers care or a site cannot complete a required activity. It should not promise that all follow-up will continue unchanged if an approved change specifies otherwise; instead, it should tell staff which controlled instruction governs and whom to contact when circumstances differ.

Worked Example: Assigning Follow-Up After Closure

Hypothetical scenario. Arm C closes to recruitment on 1 June. A site’s reconciliation lists 18 participants assigned to the arm: 11 have a next protocol visit due, four have completed scheduled follow-up, and three have discontinued study treatment but still have follow-up obligations specified by the protocol.

The participant categories reconcile as \(11 + 4 + 3 = 18\). This arithmetic is a simple completeness check, not a clinical decision. The closure notice does not remove any of the 11 due visits or the three participants’ specified follow-up obligations. The four who completed scheduled follow-up are recorded as complete, subject to the protocol’s definitions and any outstanding required activities.

The site investigator remains responsible for participant-level conduct, while the designated operational contact tracks the reconciliation and escalates missed or uncertain activities. The site reports each due visit as completed, not completed with reason, or not yet due, according to the approved process. If the central list says 11 visits are due but the site can account for only 10, the discrepancy is assigned to a named owner for resolution; it is not silently removed from the list.

A closure dashboard should therefore distinguish “no longer recruiting” from “participant follow-up complete.” Combining those states would make it easy to overlook continuing obligations.

Opening or Changing an Arm: Communicate a Site-Ready Instruction

When an arm opens, the communication must identify the activation conditions that sites need to verify before recruitment starts. These may include confirmation that the current approved documents and required training are in place, that the site has received the operational instructions, and that the activation authority has confirmed the site’s status. The site should not infer that platform-level approval alone means it is ready to recruit.

When an arm changes, define which participants and activities are affected and from when. A change to a visit schedule, treatment procedure, or operational workflow may require different instructions for participants already in follow-up than for those not yet assigned. The transition notice should identify the governing approved document and explain whether a site must await a participant-specific instruction. It should not rely on informal verbal summaries to resolve differences between document versions.

Worked Example: Implementing a Revised Visit Schedule

Hypothetical scenario. An authorized amendment changes a follow-up visit window for Arm D from days 26–30 to days 25–33. The amendment and site instructions specify that the new window applies to visits with target dates on or after 1 September. A participant’s next visit has a target date of 28 August; another participant’s target date is 4 September.

For the 28 August target date, the existing window applies because the target date precedes 1 September. Its permitted dates are day 26 through day 30, inclusive: five calendar days. For the 4 September target date, the revised window applies. Its permitted dates are day 25 through day 33, inclusive: nine calendar days. The inclusive count is \(33 - 25 + 1 = 9\) days.

The site should not apply the new window retroactively to the first visit merely because the visit itself occurs after the amendment was announced. The stated applicability rule uses the target date, not the announcement date or the actual visit date. The site lead updates scheduling instructions, confirms staff have the current amendment, and records any visit that falls outside the applicable window for review under the protocol’s deviation process.

Diagnostics, Alternatives, and Common Pitfalls

Useful transition diagnostics test whether the instruction reached the people who must act and whether the resulting records agree. Check for missing site acknowledgements, activity recorded after a cutoff, participants without an assigned follow-up owner, duplicate or inconsistent status entries, and unresolved questions near the effective time. Where feasible, compare the central arm-status record with site-level recruitment and follow-up records. A discrepancy is a signal to investigate, not evidence by itself that a participant or site acted improperly.

Two broad implementation approaches are common. A single blanket instruction is fast and may suit a genuinely uniform change, but it can obscure different participant stages or site readiness. A staged transition separates tasks—for example, first pausing recruitment, then confirming site receipt, then applying the approved participant instructions. Staging takes more coordination, but it makes dependencies and exceptions visible. The choice should reflect the authorized decision, urgency, and operational complexity; neither approach substitutes for a clear effective boundary.

Centralized communications can help keep wording consistent, while a site contact can clarify local implementation and confirm completion. A purely central message may not reveal whether staff understood or acted on it. A purely local interpretation risks inconsistent instructions across sites. A robust process uses one controlled source of instruction, an identified site-level recipient, a defined acknowledgement method, and a central route for unresolved questions.

  • Pitfall: treating arm closure as participant discontinuation. This confuses recruitment status with individual follow-up. Keep the participant plan governed by the approved protocol and explicit transition instructions.
  • Pitfall: using an ambiguous cutoff. “End of day” can mean different times at different sites. State a date, time, time zone, and the activity used to apply the boundary.
  • Pitfall: treating a sent email as implementation. Sending proves transmission, not receipt or action. Obtain acknowledgements and reconcile site records.
  • Pitfall: allowing local improvisation to fill a gap. If an instruction does not cover a case, sites should use the stated escalation route rather than inventing a new rule.

These controls have limits. A reconciliation cannot guarantee that every clinical obligation has been met, and an acknowledgement does not demonstrate correct implementation by itself. The plan must remain consistent with approved documents and applicable requirements, and it must be updated if a new authorized decision changes the transition. Governance records make responsibility and follow-through visible; they do not replace clinical judgment or required oversight.

Key takeaway: Govern arm transitions by separating arm status, recruitment activity, and participant follow-up. Define the effective boundary, assign an owner for each action, communicate through controlled instructions, and reconcile evidence of implementation across sites.

Check Your Understanding

Answer each question, then compare your reasoning with the solutions.

  1. An arm closes to randomization at 12:00 local time, but participating sites are in three time zones. What information is missing from the cutoff?
  2. A participant was randomized before an arm closed. Does closure alone establish that follow-up stops? Explain.
  3. A transition notice was sent to every site, but two sites have not acknowledged it. Is implementation confirmed? What should happen next?
  4. A revised visit window applies to target dates on or after 1 November. A visit target date is 30 October, although the visit will occur on 2 November. Which applicability rule governs?
  5. A site’s participant follow-up list has 14 people, but the central record has 15. What is the appropriate governance response?

Solutions. (1) The notice needs one unambiguous reference time and time zone, or explicitly defined local-time cutoffs with their corresponding boundaries; “12:00 local time” alone can produce different simultaneous cutoffs. (2) No. Closure changes the arm’s operational status; follow-up remains governed by the approved protocol and explicit transition instructions. (3) No. The responsible owner should follow up with those sites, confirm receipt and understanding, and record resolution before treating implementation as complete. (4) The stated rule uses the target date, so the existing visit window applies because 30 October precedes 1 November. (5) Reconcile the records, identify the missing or differently classified participant, assign an owner and escalation route, and document the resolution rather than changing either count without explanation.

Clinical Biostats